Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Autologous platelet growth factor is a biologic preparation derived from a patient's own blood, specifically processed to concentrate growth factors released from activated platelets. These factors, including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and transforming growth factor-beta (TGF-β), are essential for tissue regeneration, angiogenesis, and cellular proliferation. In the context of androgenetic alopecia, this therapy is administered via local scalp injections to stimulate hair follicle activity and improve hair density. A specific mechanized freeze-dried formulation developed by Ruijin Hospital aims to provide a more stable and standardized alternative to traditional liquid autologous preparations like Concentrated Growth Factors (CGF).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on autologous platelet growth factor.